CM
RMD icon

Capula Management’s ResMed RMD Stock Holding History

Capula Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$22.4K Hold
100
– – ﹤0.01% 1037
2025
Q4 		$24.1K Hold
100
– – ﹤0.01% 788
2025
Q3 		$27.4K Buy
+100
New +$27.3K ﹤0.01% 776

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capula Management's RMD Position: Q1 2026 in Review

Capula Management increased its ResMed (RMD) stake by 16% in Q1 2026, buying an estimated $43.6K and bringing the position to 1,303 shares worth $292K. The position accounts for ﹤0.01% of the portfolio, ranked #654.

Capula Management first reported a position in RMD in Q3 2021 and has held it in 7 quarters since. The position peaked at $494K in Q2 2023. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Capula Management held 1,303 shares of ResMed worth $292K as of Q1 2026.
  • Capula Management bought 175 ResMed shares in Q1 2026, an estimated $43.6K.
  • ResMed made up ﹤0.01% of Capula Management's portfolio in Q1 2026, its #654 holding.
  • Capula Management first reported a position in ResMed in Q3 2021 and has held it in 7 quarters since.
  • Capula Management's ResMed position peaked at $494K in Q2 2023.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Capula Management's 13F filing for Q1 2026, filed 14 May 2026.